Amneal Pharmaceuticals Inc (NASDAQ: AMRX) is 12.85% higher on its value in year-to-date trading and has touched a low of $2.29 and a high of $6.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AMRX stock was last observed hovering at around $6.75 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $6.85, the stock is 2.09% and 9.79% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.46 million and changing 1.48% at the moment leaves the stock 31.61% off its SMA200. AMRX registered 185.42% gain for a year compared to 6-month gain of 46.06%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 5.87% loss in the last 1 month and extending the period to 3 months gives it a 27.32%, and is 3.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.20% over the week and 3.25% over the month.
Amneal Pharmaceuticals Inc (AMRX) has around 7850 employees, a market worth around $2.11B and $2.50B in sales. Fwd P/E is 10.10. Profit margin for the company is -6.76%. Distance from 52-week low is 199.13% and -1.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.88%).
The EPS is expected to shrink by -3.13% this year.
Amneal Pharmaceuticals Inc (AMRX) Top Institutional Holders
The shares outstanding are 306.56M, and float is at 111.08M with Short Float at 2.77%.
Amneal Pharmaceuticals Inc (AMRX) Insider Activity
The most recent transaction is an insider sale by Autor Deborah M.,the company’sDirector. SEC filings show that Autor Deborah M. sold 23,447 shares of the company’s common stock on May 17 ’24 at a price of $6.73 per share for a total of $0.16 million. Following the sale, the insider now owns 93402.0 shares.
Amneal Pharmaceuticals Inc disclosed in a document filed with the SEC on May 16 ’24 that Autor Deborah M. (Director) sold a total of 14,553 shares of the company’s common stock. The trade occurred on May 16 ’24 and was made at $6.76 per share for $98378.0. Following the transaction, the insider now directly holds 0.12 million shares of the AMRX stock.
Still, SEC filings show that on Aug 11 ’23, BOYER ANDREW S (Executive Vice President) disposed off 29,302 shares at an average price of $4.13 for $0.12 million. The insider now directly holds 244,739 shares of Amneal Pharmaceuticals Inc (AMRX).
